ERBB2 and breast cancer: In addition, while published reports have documented ultrasound/MRI targeted imaging of HER-2 positive breast cancer cells, [35, 36] we believe that this novel conjugate provides a more therapeutically meaningful option by combining CT and MRI targeted imaging for the early detection of HER-2 positive breast cancer.